Jeffrey Robert Ajer Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jeffrey Robert Ajer.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jeffrey Robert Ajer. Jeffrey Robert Ajer is a Director in NEKTAR THERAPEUTICS ($NKTR) and a EVP, Chief Commercial Officer in BIOMARIN PHARMACEUTICAL INC ($BMRN) and a SVP, Chief Commercial Of in BIOMARIN PHARMACEUTICAL INC ($BMRN) and a SVP, Chief Commercial Officer in BIOMARIN PHARMACEUTICAL INC ($BMRN).
Address: C/O BIOMARIN PHARMACEUTICAL INC., 105 DIGITAL DRIVE NOVATO 94949 CA
Companies in which Jeffrey Robert Ajer is an Insider
BIOMARIN PHARMACEUTICAL INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jeffrey Robert Ajer: EVP, Chief Commercial Officer, SVP, Chief Commercial Officer, SVP, Chief Commercial Of
Holdings: 58,250 shares
Current Value: $5,179,008
Latest Transaction: Apr 09 2021
$BMRN Market Capitalization: $15.63B
$BMRN Previous Close: $88.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NEKTAR THERAPEUTICS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jeffrey Robert Ajer: Director
Holdings: 25,975 shares
Current Value: $342,091
Latest Transaction: Sep 30 2020
$NKTR Market Capitalization: $2.01B
$NKTR Previous Close: $13.17
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Jeffrey Robert Ajer
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 09 2021 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Sell | S | 78.81 | 1,537 | 121,131 | 58,250 | 59.8 K to 58.3 K (-2.57 %) |
| Apr 01 2021 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Sell | S | 74.79 | 1,652 | 123,553 | 59,787 | 61.4 K to 59.8 K (-2.69 %) |
| Mar 26 2021 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Sell | S | 76.30 | 1,181 | 90,110 | 61,439 | 62.6 K to 61.4 K (-1.89 %) |
| Mar 26 2021 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Sell | S | 76.30 | 1,181 | 90,110 | 61,439 | 62.6 K to 61.4 K (-1.89 %) |
| Mar 23 2021 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Payment of Exercise | F | 78.52 | 1,513 | 118,801 | 62,620 | 64.1 K to 62.6 K (-2.36 %) |
| Mar 19 2021 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Sell | S | 77.99 | 1,308 | 102,011 | 64,133 | 65.4 K to 64.1 K (-2.00 %) |
| Mar 19 2021 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Sell | S | 77.99 | 1,308 | 102,011 | 64,133 | 65.4 K to 64.1 K (-2.00 %) |